Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
16,19 CNY | -0,37 % | +9,54 % | +29,42 % |
Resumen de negocios
Número de empleados: 476
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Crude Urokinase
43,0
%
| 103 | 42,3 % | 177 | 43,0 % | +71,46 % |
Ulinastatin Crude
19,3
%
| 40 | 16,4 % | 80 | 19,3 % | +98,15 % |
Senna Granules
15,6
%
| 50 | 20,3 % | 64 | 15,6 % | +29,63 % |
New HIV Drug (Enomitide Tablets)
11,9
%
| - | - | 49 | 11,9 % | - |
New HIV Drug (EnovirineTablets)
6,0
%
| 33 | 13,7 % | 25 | 6,0 % | -26,15 % |
HIV Diagnostic Reagents
1,8
%
| 12 | 5,0 % | 7 | 1,8 % | -40,95 % |
Bacillus Cereus Tablets
1,0
%
| 3 | 1,4 % | 4 | 1,0 % | +19,19 % |
Other Crude Human Protein
0,8
%
| 0 | 0,0 % | 3 | 0,8 % | +6.509,67 % |
Other Business
0,6
%
| 1 | 0,6 % | 2 | 0,6 % | +69,38 % |
Other Generic Drugs
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | -997,00 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 244 | 100,0 % | 411 | 100,0 % | +68,44 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Chuanhong Zhu
DFI | Director of Finance/CFO | 53 | 16/09/23 |
He Liang Fu
CHM | Chairman | 63 | 01/01/14 |
Qi Hong
CTO | Chief Tech/Sci/R&D Officer | 61 | 19/01/21 |
Jun Wang
COO | Chief Operating Officer | 50 | 01/01/14 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01/01/15 |
Wei Xuan Zhou
IRC | Investor Relations Contact | 34 | 01/08/20 |
Yan Liu
SEC | Corporate Secretary | 42 | 14/03/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
He Liang Fu
CHM | Chairman | 63 | 01/01/14 |
Guang Ji Wang
BRD | Director/Board Member | 71 | 09/05/19 |
Xiao Yan Qi
BRD | Director/Board Member | 61 | 10/03/22 |
Guang Rong Wang
BRD | Director/Board Member | 48 | 01/01/15 |
Jun Wang
COO | Chief Operating Officer | 50 | 01/01/14 |
Heng Yu
CHM | Chairman | 44 | 01/12/09 |
Feng Ying He
BRD | Director/Board Member | 41 | 01/12/14 |
Zijian Guo
BRD | Director/Board Member | 63 | 15/09/23 |
Jie Zhang
CEO | Chief Executive Officer | 54 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 420 782 808 | 185 754 481 ( 44,14 %) | 0 | 44,14 % |
Información de la empresa
Jiangsu Aidea Pharmaceutical Co., Ltd.
No.69 New Ganquan West Road Hanjiang District
225008, Yangzhou
+
http://www.aidea.com.cnVentas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,42 % | 948 M | |
-2,35 % | 89,33 mil M | |
+4,08 % | 41,19 mil M | |
-15,09 % | 31,87 mil M | |
+53,68 % | 24,52 mil M | |
-15,13 % | 15,68 mil M | |
-8,63 % | 12,34 mil M | |
-40,39 % | 12,23 mil M | |
+6,22 % | 8825,46 M | |
-6,43 % | 8278,09 M |
- Bolsa de valores
- Acciones
- Acción 688488
- Empresa Jiangsu Aidea Pharmaceutical Co., Ltd.